Cargando…

Progress with PfSPZ Vaccine, a radiation attenuated Plasmodium falciparum sporozoite vaccine

Detalles Bibliográficos
Autores principales:	Billingsley, Peter, Sim, B Kim Lee, James, Eric, Richie, Thomas, Shekalaghe, Seif, Healy, Sara, Sissoko, Mahamadou, Mordmueller, Benjamin, Ledgerwood, Julie, Graham, Barney, Duffy, Patrick, Seder, Robert, Lyke, Kirsten, Epstein, Judith, Alonso, Pedro, Abdullah, Salim, Duombo, Ogobara, Kremsner, Peter, Tanner, Marcel, Hoffman, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179253/ http://dx.doi.org/10.1186/1475-2875-13-S1-O34

Ejemplares similares

Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
por: Richie, Thomas L., et al.
Publicado: (2015)

Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa
por: Silva, Joana C., et al.
Publicado: (2022)

Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy
por: KC, Natasha, et al.
Publicado: (2022)

Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants
por: Jongo, Said A., et al.
Publicado: (2019)

Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults
por: Jongo, Said A., et al.
Publicado: (2023)

A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection
por: Mordmüller, Benjamin, et al.
Publicado: (2022)

Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults
por: Jongo, Said A., et al.
Publicado: (2021)

PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
por: Coulibaly, Drissa, et al.
Publicado: (2022)

Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
por: Sulyok, Zita, et al.
Publicado: (2021)

Adaptive clinical trials of three PfSPZ products for development of a whole sporozoite vaccine that prevents Plasmodium falciparum infection, disease and transmission
por: Hoffman, Stephen L
Publicado: (2012)

Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults
por: Jongo, Said Abdallah, et al.
Publicado: (2022)

Caregiver and community perceptions and experiences participating in an infant malaria prevention trial of PfSPZ Vaccine administered by direct venous inoculation: a qualitative study in Siaya County, western Kenya
por: Achieng, Florence, et al.
Publicado: (2020)

Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men
por: Olotu, Ally, et al.
Publicado: (2018)

1241. PfSPZ Vaccine Administered by Direct Venous Inoculation to Prevent Plasmodium falciparum Malaria is as Safe as Normal Saline – a Meta-analysis of 12 Randomized Controlled Clinical Trials
por: Church, L W Preston
Publicado: (2020)

Controlled human malaria infections using aseptic, purified cryopreserved Plasmodium falciparum sporozoites administered by needle and syringe
por: Billingsley, Peter, et al.
Publicado: (2014)

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection
por: Murphy, Sean C., et al.
Publicado: (2021)

Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
por: Scally, Stephen W., et al.
Publicado: (2018)

Development of an attenuated sporozoite vaccine to prevent and eliminate Plasmodium falciparum malaria
por: Billingsley, Peter F
Publicado: (2010)

Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults
por: Jongo, Said A., et al.
Publicado: (2018)

A First for Human Vaccinology: GMP Compliant Radiation Attenuation of Plasmodium falciparum Sporozoites for Production of a Vaccine Against Malaria
por: James, Eric R., et al.
Publicado: (2022)

Vaccination With Sporozoites: Models and Correlates of Protection
por: Goh, Yun Shan, et al.
Publicado: (2019)

Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens
por: Ibanez, Javier, et al.
Publicado: (2022)

The impact of Loa loa microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea
por: Manock, Stephen R, et al.
Publicado: (2022)

Optimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria Infection
por: Lyke, Kirsten E., et al.
Publicado: (2015)

The Development of Whole Sporozoite Vaccines for Plasmodium falciparum Malaria
por: Itsara, Leslie S., et al.
Publicado: (2018)

Novel approaches to whole sporozoite vaccination against malaria(✩)
por: Bijker, Else M., et al.
Publicado: (2015)

Spz/Toll-6 signal guides organotropic metastasis in Drosophila
por: Mishra-Gorur, Ketu, et al.
Publicado: (2019)

Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine
por: Ellis, Ruth D, et al.
Publicado: (2011)

Five decades of clinical assessment of whole-sporozoite malaria vaccines
por: Nunes-Cabaço, Helena, et al.
Publicado: (2022)

Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites
por: Atre, Tanmaya, et al.
Publicado: (2019)

A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection
por: Zanghì, Gigliola, et al.
Publicado: (2018)

Dynamics of Polymorphism in a Malaria Vaccine Antigen at a Vaccine-Testing Site in Mali
por: Takala, Shannon L, et al.
Publicado: (2007)

The road to Cybathlon 2016 - Functional electrical stimulation cycling Team IRPT/SPZ
por: Laubacher, Marco, et al.
Publicado: (2017)

Malian adults maintain serologic responses to virulent PfEMP1s amid seasonal patterns of fluctuation
por: Ventimiglia, Noah T., et al.
Publicado: (2021)

Longitudinal analysis of gamma delta T cell subsets during malaria infections in Malian adults
por: Diallo, Hama, et al.
Publicado: (2019)

Controlled Human Malaria Infection of Tanzanians by Intradermal Injection of Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites
por: Shekalaghe, Seif, et al.
Publicado: (2014)

The Ability to Inoculate Purified Malaria Sporozoites Will Accelerate Vaccine and Drug Discovery
por: Good, Michael F.
Publicado: (2014)

Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali
por: Coulibaly, Drissa, et al.
Publicado: (2014)

Transcript and protein expression profile of PF11_0394, a Plasmodium falciparum protein expressed in salivary gland sporozoites
por: Schlarman, Maggie S, et al.
Publicado: (2012)

Use of insecticide-treated nets (ITNs) following a malaria education intervention in Piron, Mali: a control trial with systematic allocation of households
por: Rhee, Michelle, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_hlele2pcni0c4csn0p67psiukv